{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:25:00Z","timestamp":1792113900376,"version":"4.4.0"},"reference-count":58,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.20836","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T11:41:56Z","timestamp":1603107716000},"page":"e2020836","source":"Crossref","is-referenced-by-count":180,"title":["Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults"],"prefix":"10.1001","volume":"3","author":[{"given":"Daniel","family":"Rooks","sequence":"first","affiliation":[{"name":"Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Swan","sequence":"additional","affiliation":[{"name":"Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budhaditya","family":"Goswami","sequence":"additional","affiliation":[{"name":"Novartis Healthcare, Hyderabad, India"},{"name":"Now with MorphoSys, Planegg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Anne","family":"Filosa","sequence":"additional","affiliation":[{"name":"Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Bunte","sequence":"additional","affiliation":[{"name":"Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Panchaud","sequence":"additional","affiliation":[{"name":"Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Coleman","sequence":"additional","affiliation":[{"name":"Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram R.","family":"Miller","sequence":"additional","affiliation":[{"name":"Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Garcia Garayoa","sequence":"additional","affiliation":[{"name":"Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Praestgaard","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Perry","sequence":"additional","affiliation":[{"name":"Panax Clinical Research, Miami Lakes, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Recknor","sequence":"additional","affiliation":[{"name":"Center for Advanced Research and Education, Gainesville, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Fogarty","sequence":"additional","affiliation":[{"name":"Spartanburg Medical Research, Spartanburg, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Arai","sequence":"additional","affiliation":[{"name":"National Center for Geriatrics and Gerontology, Obu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Kung","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"National Hospital Organization, Osaka Minami Medical Center, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Sok","family":"Chung","sequence":"additional","affiliation":[{"name":"Ajou University School of Medicine, Suwon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[{"name":"Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Laurent","sequence":"additional","affiliation":[{"name":"Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Petricoul","sequence":"additional","affiliation":[{"name":"Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hemsley","sequence":"additional","affiliation":[{"name":"Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Lach-Trifilieff","sequence":"additional","affiliation":[{"name":"Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris A.","family":"Papanicolaou","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronenn","family":"Roubenoff","sequence":"additional","affiliation":[{"name":"Translational Medicine and Musculoskeletal Diseases Research, Novartis Institutes for BioMedical Research, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"issue":"1","key":"zoi200718r2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis.","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"2","key":"zoi200718r3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.berh.2017.11.007","article-title":"Sarcopenia.","volume":"31","author":"Fuggle","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"zoi200718r4","first-page":"2","article-title":"Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the International Conference on Frailty and Sarcopenia Research Task Force.","volume":"7","author":"Vellas","year":"2018","journal-title":"J Frailty Aging"},{"issue":"5","key":"zoi200718r5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jcsm.v7.5","article-title":"Welcome to the ICD-10 code for sarcopenia.","volume":"7","author":"Anker","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"zoi200718r6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5694\/mja2.v212.1","article-title":"Sarcopenia: a deserving recipient of an Australian ICD-10-AM code.","volume":"212","author":"Zanker","year":"2020","journal-title":"Med J Aust"},{"issue":"5","key":"zoi200718r7","doi-asserted-by":"publisher","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: origins and clinical relevance.","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J Nutr"},{"issue":"10","key":"zoi200718r8","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3390\/ijms19102999","article-title":"Impact of sarcopenia as a prognostic biomarker of bladder cancer.","volume":"19","author":"Fukushima","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"zoi200718r9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/thoraxjnl-2014-206440","article-title":"Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation.","volume":"70","author":"Jones","year":"2015","journal-title":"Thorax"},{"issue":"4","key":"zoi200718r10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.11005\/jbm.2018.25.4.227","article-title":"Effect of sarcopenia on postoperative mortality in osteoporotic hip fracture patients.","volume":"25","author":"Kim","year":"2018","journal-title":"J Bone Metab"},{"issue":"4","key":"zoi200718r11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People.","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"4","key":"zoi200718r12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults: current consensus definition: prevalence, etiology, and consequences: international working group on sarcopenia.","volume":"12","author":"Fielding","year":"2011","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"zoi200718r13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.","volume":"15","author":"Chen","year":"2014","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"zoi200718r14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.","volume":"69","author":"Studenski","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"zoi200718r15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/gerona\/glu013","article-title":"An evidence-based comparison of operational criteria for the presence of sarcopenia.","volume":"69","author":"Dam","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"zoi200718r16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40520-016-0715-2","article-title":"The \u201cSarcopenia and Physical Frailty in Older People: Multi-Component Treatment Strategies\u201d (SPRINTT) randomized controlled trial: design and methods.","volume":"29","author":"Landi","year":"2017","journal-title":"Aging Clin Exp Res"},{"issue":"3","key":"zoi200718r17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00198-018-04828-0","article-title":"The relationship between sarcopenia and fragility fracture-a systematic review.","volume":"30","author":"Wong","year":"2019","journal-title":"Osteoporos Int"},{"issue":"1","key":"zoi200718r18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12877-016-0349-4","article-title":"Sarcopenia in daily practice: assessment and management.","volume":"16","author":"Beaudart","year":"2016","journal-title":"BMC Geriatr"},{"issue":"10","key":"zoi200718r19","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","article-title":"International Clinical Practice Guidelines for Sarcopenia (ICFSR): screening, diagnosis and management.","volume":"22","author":"Dent","year":"2018","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"zoi200718r20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/1559827613488867","article-title":"Long-term adherence to health behavior change.","volume":"7","author":"Middleton","year":"2013","journal-title":"Am J Lifestyle Med"},{"issue":"23","key":"zoi200718r21","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1001\/jama.2014.5616","article-title":"Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial.","volume":"311","author":"Pahor","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"zoi200718r22","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/jcsm.v9.7","article-title":"Treatment of sarcopenia: the road to the future.","volume":"9","author":"Morley","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"zoi200718r23","first-page":"120","article-title":"Development of pharmacotherapies for the treatment of Sarcopenia.","volume":"8","author":"Rooks","year":"2019","journal-title":"J Frailty Aging"},{"issue":"3","key":"zoi200718r24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mus.23539","article-title":"A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers.","volume":"47","author":"Attie","year":"2013","journal-title":"Muscle Nerve"},{"issue":"12","key":"zoi200718r25","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial.","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"zoi200718r26","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/jgs.2017.65.issue-9","article-title":"Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study.","volume":"65","author":"Rooks","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"zoi200718r27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy.","volume":"34","author":"Lach-Trifilieff","year":"2014","journal-title":"Mol Cell Biol"},{"issue":"47","key":"zoi200718r28","doi-asserted-by":"publisher","first-page":"12448","DOI":"10.1073\/pnas.1707925114","article-title":"Blockade of activin type II receptors with a dual anti-ActRIIA\/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.","volume":"114","author":"Morvan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"zoi200718r29","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"zoi200718r30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group.","volume":"14","author":"Bauer","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"zoi200718r31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.clnu.2014.04.007","article-title":"Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group.","volume":"33","author":"Deutz","year":"2014","journal-title":"Clin Nutr"},{"issue":"3","key":"zoi200718r32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1017\/S1368980018002951","article-title":"Dietary assessment toolkits: an overview.","volume":"22","author":"Dao","year":"2019","journal-title":"Public Health Nutr"},{"issue":"2","key":"zoi200718r33","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"issue":"4","key":"zoi200718r34","doi-asserted-by":"publisher","first-page":"M221","DOI":"10.1093\/gerona\/55.4.M221","article-title":"Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery.","volume":"55","author":"Guralnik","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"zoi200718r35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12916-016-0763-7","article-title":"Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis.","volume":"14","author":"Pavasini","year":"2016","journal-title":"BMC Med"},{"issue":"5","key":"zoi200718r36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/(ISSN)1532-5415","article-title":"Meaningful change and responsiveness in common physical performance measures in older adults.","volume":"54","author":"Perera","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"zoi200718r37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test.","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"zoi200718r38","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1532-5415.2003.51104.x","article-title":"Physical performance measures in the clinical setting.","volume":"51","author":"Studenski","year":"2003","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"zoi200718r39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ageing\/afr051","article-title":"A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach.","volume":"40","author":"Roberts","year":"2011","journal-title":"Age Ageing"},{"issue":"7","key":"zoi200718r40","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","article-title":"Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.","volume":"22","author":"Janssen","year":"2013","journal-title":"Qual Life Res"},{"issue":"12","key":"zoi200718r41","doi-asserted-by":"publisher","first-page":"M772","DOI":"10.1093\/gerona\/57.12.M772","article-title":"Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.","volume":"57","author":"Iannuzzi-Sucich","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9","key":"zoi200718r44","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1474-4422(19)30200-5","article-title":"Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.","volume":"18","author":"Hanna","year":"2019","journal-title":"Lancet Neurol"},{"issue":"5","key":"zoi200718r45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/cpdd.v7.5","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of domagrozumab (PF-06252616), an antimyostatin monoclonal antibody, in healthy subjects.","volume":"7","author":"Bhattacharya","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"zoi200718r46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13395-015-0060-8","article-title":"Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice.","volume":"5","author":"Latres","year":"2015","journal-title":"Skelet Muscle"},{"issue":"5","key":"zoi200718r47","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/jcsm.v8.5","article-title":"Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy.","volume":"8","author":"Rooks","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"zoi200718r48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1164\/rccm.201802-0286OC","article-title":"Activin type II receptor blockade for treatment of muscle depletion in chronic obstructive pulmonary disease. a randomized trial.","volume":"199","author":"Polkey","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"24","key":"zoi200718r49","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1212\/WNL.0000000000001070","article-title":"Treatment of sporadic inclusion body myositis with bimagrumab.","volume":"83","author":"Amato","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"zoi200718r50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00223-015-9964-x","article-title":"Emerging impact of skeletal muscle in health and disease.","volume":"96","author":"Fielding","year":"2015","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"zoi200718r51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12603-013-0335-x","article-title":"A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia.","volume":"17","author":"Papanicolaou","year":"2013","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"zoi200718r52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/gerona\/glq183","article-title":"Testosterone threshold levels and lean tissue mass targets needed to enhance skeletal muscle strength and function: the HORMA trial.","volume":"66","author":"Sattler","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"zoi200718r53","first-page":"583","article-title":"Effects of testosterone supplementation for 3 years on muscle performance and physical function in older men.","volume":"102","author":"Storer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"zoi200718r54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration.","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi200718r55","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00198-017-3980-9","article-title":"Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review.","volume":"28","author":"Beaudart","year":"2017","journal-title":"Osteoporos Int"},{"issue":"9","key":"zoi200718r56","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCULATIONAHA.107.185650","article-title":"Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association.","volume":"116","author":"Nelson","year":"2007","journal-title":"Circulation"},{"key":"zoi200718r57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s11556-019-0230-5","article-title":"Effects of resistance training on self-reported disability in older adults with functional limitations or disability\u2014a systematic review and meta-analysis.","volume":"16","author":"Olsen","year":"2019","journal-title":"Eur Rev Aging Phys Act"},{"issue":"6","key":"zoi200718r58","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.cmet.2016.05.007","article-title":"Exercise promotes healthy aging of skeletal muscle.","volume":"23","author":"Cartee","year":"2016","journal-title":"Cell Metab"},{"key":"zoi200718r1","volume-title":"An Aging World: 2015","author":"He","year":"2016"},{"key":"zoi200718r43","author":"Coleman","year":"2019"},{"key":"zoi200718r42","unstructured":"Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE): version 5.0. Accessed May 16, 2020. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2771858\/rooks_2020_oi_200718_1602262574.00079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T11:42:27Z","timestamp":1603107747000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2771858"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.20836","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]}}}